Nucleus Accumbens Deep Brain Stimulation: Distinguishing Mechanistic Target Engagement From Clinical Efficacy
Journal of Neurochemistry · 2026-11 · 170 (11)
DOI: 10.1111/jnc.70587 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Neurochemistry, online erschienen am 09.11.2026. Verfasst von Sebastian McCullough und 4 weiteren Autor:innen. Beteiligte Einrichtung: Functional Neuromodulation and Novel Therapeutics Laboratory, Queensland Brain Institute, Asia Pacific Centre for Neuromodulation, The University of …. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Functional Neuromodulation and Novel Therapeutics Laboratory, Queensland Brain Institute, Asia Pacific Centre for Neuromodulation, The University of Queensland, St Lucia, Queensland, Australia.
ORCID-Profile: Roger B Varela, Susannah J Tye
Zitieren
APA
McCullough, S., Varela, R. B., Houghton, T., Cruickshank, H., & Tye, S. J. (2026). Nucleus Accumbens Deep Brain Stimulation: Distinguishing Mechanistic Target Engagement From Clinical Efficacy. Journal of Neurochemistry, 170(11). https://doi.org/10.1111/jnc.70587
Vancouver
McCullough S, Varela RB, Houghton T, Cruickshank H, Tye SJ. Nucleus Accumbens Deep Brain Stimulation: Distinguishing Mechanistic Target Engagement From Clinical Efficacy. Journal of Neurochemistry. 2026;170(11). doi:10.1111/jnc.70587
BibTeX
@article{McCullough2026,
author = {McCullough, Sebastian and Varela, Roger B and Houghton, Tristan and Cruickshank, Heather and Tye, Susannah J},
title = {Nucleus Accumbens Deep Brain Stimulation: Distinguishing Mechanistic Target Engagement From Clinical Efficacy},
journal = {Journal of Neurochemistry},
year = {2026},
volume = {170},
number = {11},
doi = {10.1111/jnc.70587}
}
EUVIMED